VBI Vaccines, Inc. - Ordinary Shares (VBIV) Social Stream



VBI Vaccines, Inc. - Ordinary Shares (VBIV): $0.60

0.01 (+1.50%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add VBIV to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#190 of 348

in industry

VBI VACCINES INC (VBIV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VBI VACCINES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 3 $9 $8 $8.5 $0.62 1270.97%
2022-03-07 3 $9 $6 $7.666 $0.62 1136.45%
2022-05-11 2 $8 $6 $6.666 $0.62 975.16%
2022-08-08 3 $8 $6 $6.666 $0.62 975.16%
2022-08-09 3 $7 $5 $6 $0.62 867.74%
2022-11-11 3 $7 $2 $5 $0.62 706.45%
2023-03-14 2 $60.06 $60.06 $60.06 $0.62 9587.1%
2023-08-14 2 $60.06 $6 $33.03 $0.62 5227.42%
2023-10-26 2 $6 $2 $4 $0.62 545.16%

The Trend in the Analyst Price Target


VBIV's average price target has moved down $0 over the prior 50 weeks.

VBIV reports an average of 3,413.99% for its upside potential over the past 32 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-14 2 2.00 2 2.00 0.365 447.95%
2023-04-13 2 60.06 6 33.03 2.960 1015.88%
2023-07-10 2 60.06 6 33.03 1.460 2162.33%
2023-08-14 2 60.06 6 33.03 1.350 2346.67%
2023-10-26 2 6.00 2 4.00 0.604 562.25%

VBIV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

The Trend in the Broker Recommendations


Over the past 92 days, VBIV's average broker recommendation rating improved by 0.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VBIV as an investment opportunity.

  • VBI VACCINES INC's upside potential (average analyst target price relative to current price) is higher than 1061.9% of all US stocks.
  • VBIV has a greater number of analysts covering the stock than 58.2% of all US stocks.
  • In terms of how VBI VACCINES INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 294.17% of that group.
  • In terms of how VBI VACCINES INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -219.91% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to VBI VACCINES INC are ATNF, GTHX, and MRSN.

Is VBIV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!